Picture of Memphasys logo

MEM — Memphasys Balance Sheet

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Memphasys, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
R2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Short Term Investments
Cash and Short Term Investments0.2690.6810.2780.2981.18
Net Total Accounts Receivable
Net Total Receivables1.51.3200.9010.547
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets2.032.250.51.332.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment2.342.10.7080.5670.233
Net Intangible Assets
Long Term Investments
Total Assets14.114.711.511.211.2
Accounts Payable
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities4.545.575.256.597.02
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities6.477.285.596.877.02
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity7.657.385.914.344.21
Total Liabilities & Shareholders' Equity14.114.711.511.211.2
Total Common Shares Outstanding